Drug Pricing
Commentary
Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic
The value of innovative medicines has absolutely nothing to do with its cost of production. Yet, not only does this myth persist, it appears to be growing. In the latest example, an article in the Journal of Virus Eradication claims that drugs being repurposed in the hopes they might be effective treatments for ...
Blog
What We’re Watching – August 14
Tim Anaya – Reforming Patient Costs at the Pharmacy In the latest video in the Pacific Research Institute “Escape the Drug Pricing Maze” series, the Professor and Pete must collect 3 keys to finally escape the drug pricing maze. The first key involves reforms to increase drug affordability for patients ...
Blog
What We’re Watching – July 31
Rowena Itchon – A Tribute to Herman Cain https://youtu.be/2qeFfGpJ2m8 Kerry Jackson – Ricky Gervais gives the ‘cancel culture cretins’ a massive serve “Just because you’re offended, doesn’t make you right,” comedian Ricky Gervais says. He could have also said that just because you’re offended, it doesn’t give you the right to ...
Commentary
Trump’s drug pricing executive orders harmful to patients — will hinder development of new drugs
President Trump issued four executive orders Friday that he said will lower drug prices — but in reality, three of the orders will cause far more harm than good and represent electioneering at its worst. The three harmful executive orders allow the importation of drugs from Canada, reduce the price ...
Drug Pricing
Sally Pipes and Lars Larson Examine Trump Ex. Orders on Drug Pricing
Sally C. Pipes joins the Lars Larson Show to question the Trump administration’s latest action on drug pricing. President Trump plans to sign an executive order on Friday, July 24 that puts limits on drug pricing in the United States. Pipes explains that 90 percent of drugs are generic and ...
Commentary
Executive Order On Drug Price Controls Would Backfire
Rumor has it that President Trump will soon issue a sweeping executive order to lower prescription drug prices by fiat. Nothing is set in stone. But the order would reportedly index the government’s reimbursements for medicines to the prices that Britain, France, Canada, and other developed nations pay. Since all those nations ...
Commentary
Patients Will Suffer The Most From The Trump Administration’s Reference Pricing Scheme
The pharmaceutical industry has responded to the Covid-19 pandemic with, arguably, the greatest surge in drug innovation in history. Consider that Remdesivir (produced by Gilead) has already received an emergency use authorization by the FDA for Covid-19. Losmapimod (produced by Fulcrum) is another promising treatment for Covid-19 that is in Phase III trials. And, ...
Drug Pricing
What We’re Watching – July 17
Rowena Itchon – 102-year-old woman survives 1918 pandemic, COVID-19 Gerri Schappals is 102, and survived the Spanish flu, cancer, and COVID-19 – an inspiration to us all. Ben Smithwick – The Black Swan Economy Jonathan Coslet, Senior Partner & Chief Investment Officer at TPG Capital, and Stanford Professor John B. ...
Commentary
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Commentary
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic
The value of innovative medicines has absolutely nothing to do with its cost of production. Yet, not only does this myth persist, it appears to be growing. In the latest example, an article in the Journal of Virus Eradication claims that drugs being repurposed in the hopes they might be effective treatments for ...
What We’re Watching – August 14
Tim Anaya – Reforming Patient Costs at the Pharmacy In the latest video in the Pacific Research Institute “Escape the Drug Pricing Maze” series, the Professor and Pete must collect 3 keys to finally escape the drug pricing maze. The first key involves reforms to increase drug affordability for patients ...
What We’re Watching – July 31
Rowena Itchon – A Tribute to Herman Cain https://youtu.be/2qeFfGpJ2m8 Kerry Jackson – Ricky Gervais gives the ‘cancel culture cretins’ a massive serve “Just because you’re offended, doesn’t make you right,” comedian Ricky Gervais says. He could have also said that just because you’re offended, it doesn’t give you the right to ...
Trump’s drug pricing executive orders harmful to patients — will hinder development of new drugs
President Trump issued four executive orders Friday that he said will lower drug prices — but in reality, three of the orders will cause far more harm than good and represent electioneering at its worst. The three harmful executive orders allow the importation of drugs from Canada, reduce the price ...
Sally Pipes and Lars Larson Examine Trump Ex. Orders on Drug Pricing
Sally C. Pipes joins the Lars Larson Show to question the Trump administration’s latest action on drug pricing. President Trump plans to sign an executive order on Friday, July 24 that puts limits on drug pricing in the United States. Pipes explains that 90 percent of drugs are generic and ...
Executive Order On Drug Price Controls Would Backfire
Rumor has it that President Trump will soon issue a sweeping executive order to lower prescription drug prices by fiat. Nothing is set in stone. But the order would reportedly index the government’s reimbursements for medicines to the prices that Britain, France, Canada, and other developed nations pay. Since all those nations ...
Patients Will Suffer The Most From The Trump Administration’s Reference Pricing Scheme
The pharmaceutical industry has responded to the Covid-19 pandemic with, arguably, the greatest surge in drug innovation in history. Consider that Remdesivir (produced by Gilead) has already received an emergency use authorization by the FDA for Covid-19. Losmapimod (produced by Fulcrum) is another promising treatment for Covid-19 that is in Phase III trials. And, ...
What We’re Watching – July 17
Rowena Itchon – 102-year-old woman survives 1918 pandemic, COVID-19 Gerri Schappals is 102, and survived the Spanish flu, cancer, and COVID-19 – an inspiration to us all. Ben Smithwick – The Black Swan Economy Jonathan Coslet, Senior Partner & Chief Investment Officer at TPG Capital, and Stanford Professor John B. ...
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
